Marketing

Physician available through market research company to discuss first cervical cancer vaccine

Published in Medical Letter on the CDC and FDA, July 16th, 2006

Dr. John Lebbos, MD, therapeutic area director at Decision Resources, is available to discuss the impact of the U.S. Food and Drug Administration's (FDA) approval of Merck's Gardasil, the first vaccine for cervical cancer.

Studies show virtually all cases of cervical cancer are caused by a virus known as human papillomavirus, or HPV. It is transmitted sexually and most of the time human immune systems can get rid of it, but in about 10,000 women a year it develops into cervical cancer.

Gardasil is expected to be available late this summer, according to Merck.

Dr. Lebbos can provide:

- Insight on the commercial...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2006-07-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry